Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jørn Herrstedt

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Safety|May 25, 2004
Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomitingJørn Herrstedt
Nature Clinical Practice. Oncology|December 22, 2007
Antiemetics: an update and the MASCC guidelines applied in clinical practiceJørn Herrstedt
Ugeskrift for Laeger|February 2, 2024
Jørn Herrstedt
Current Opinion in Oncology|April 28, 2018
The latest consensus on antiemeticsJørn Herrstedt
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 28, 2002
Nausea and emesis: still an unsolved problem in cancer patients?Jørn Herrstedt
Ugeskrift for Laeger|March 16, 2007
[Medical treatment of chemotherapy-induced nausea and vomiting]Jørn Herrstedt
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Antiemetics: state of the artJørn Herrstedt
Onkologie|February 12, 2009
The difficult trialsJørn Herrstedt
The Lancet. Oncology|June 2, 2009
Controlling chemotherapy-related nausea and vomitingJørn Herrstedt
Expert Review of Anticancer Therapy|February 6, 2010
Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomitingChristina Ruhlmann, Jørn Herrstedt
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|May 25, 2004
Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomitingJørn Herrstedt
Nature Clinical Practice. Oncology|December 22, 2007
Antiemetics: an update and the MASCC guidelines applied in clinical practiceJørn Herrstedt
Ugeskrift for Laeger|February 2, 2024
Jørn Herrstedt
Current Opinion in Oncology|April 28, 2018
The latest consensus on antiemeticsJørn Herrstedt
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 28, 2002
Nausea and emesis: still an unsolved problem in cancer patients?Jørn Herrstedt
Ugeskrift for Laeger|March 16, 2007
[Medical treatment of chemotherapy-induced nausea and vomiting]Jørn Herrstedt
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Antiemetics: state of the artJørn Herrstedt
Onkologie|February 12, 2009
The difficult trialsJørn Herrstedt
The Lancet. Oncology|June 2, 2009
Controlling chemotherapy-related nausea and vomitingJørn Herrstedt
Expert Review of Anticancer Therapy|February 6, 2010
Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomitingChristina Ruhlmann, Jørn Herrstedt
Pageof 10